The following trials provide information to treat various types of cancer and infectious disease, both for ongoing and completed clinical trials. For more information on our oncology therapy area please click here or for our infection therapy area please click here.
-
expand
Protocol for the specified clinical experience investigation on the single use of Casodex Tablet 80 mg
- Study Id
- NIS-OJP-CAS-2009/1
- Disease
- prostate cancer
- Drug Name
- Casodex
- Study Name
- NIS-OJP-CAS-2009/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 7, 2013
-
expand
A Phase III, Randomised, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of 10 mg ZD4054 in Combination With Docetaxel in Comparison With Docetaxel in Patients With Metastatic Hormone-Resistant Prostate Cancer.
- Study Id
- D4320C00033
- Disease
- prostate cancer
- Drug Name
- ZD4054
- Study Name
- D4320C00033
- Recruiting Status
- Closed
- Protocol
-
Feb 15, 2011
- Report
-
Oct 17, 2011
-
expand
A Phase I, open-label, multi-centre, multiple ascending dose study to assess the safety and tolerability of AZD1152 in combination with low dose cytosine arabinoside (LDAC) in patients with acute myeloid leukaemia (AML)
- Study Id
- D1531C00018
- Disease
- acute myeloid leukaemia
- Drug Name
- AZD1152
- Study Name
- D1531C00018
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Mar 23, 2011
-
expand
A randomised, open-label, multi-centre, 2-stage, parallel group study to assess the efficacy, safety and tolerability of AZD1152 alone and in combination with low dose cytosine arabinoside (LDAC) in comparison with LDAC alone in patients aged ? 60 with newly diagnosed acute myeloid leukaemia (AML).
- Study Id
- D1531C00009
- Disease
- acute myeloid leukaemia
- Drug Name
- AZD1152
- Study Name
- D1531C00009
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Sep 11, 2012
-
expand
A Phase I, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1152 Given as a continuous 7-day Intravenous Infusion in Patients With Advanced Solid Malignancies.
- Study Id
- D1531C00003
- Disease
- solid tumour
- Drug Name
- AZD1152
- Study Name
- D1531C00003
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Feb 9, 2009
-
expand
A Phase I, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1152 Given as a 2 Hour Intravenous Infusion on Two Dose Schedules in Patients With Advanced Solid Malignancies.
- Study Id
- D1531C00001
- Disease
- solid tumour
- Drug Name
- AZD1152
- Study Name
- D1531C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Sep 4, 2009
-
expand
AZD1152 in patients with Advanced Solid Malignancies
- Study Id
- D1531C00002
- Disease
- solid tumour
- Drug Name
- AZD1152
- Study Name
- D1531C00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Oct 23, 2009
-
expand
A Phase I Open, Non-randomised, Single-centre Study to Assess the Metabolism, Excretion and Pharmacokinetics of AZD1152 and AZD1152 hQPA Following Intravenous Administration of [14C]-AZD1152 in Patients With Acute Myeloid Leukaemia (AML)
- Study Id
- D1531C00012
- Disease
- acute myeloid leukaemia
- Drug Name
- AZD1152
- Study Name
- D1531C00012
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 10, 2011
-
expand
A phase I, open label, multi-centre study to assess the safety, tolerability, and pharmacokinetics of AZD1152 in Japanese patients with acute myeloid leukaemia.
- Study Id
- D1531C00008
- Disease
- acute myeloid leukaemia
- Drug Name
- AZD1152
- Study Name
- D1531C00008
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Apr 23, 2010
-
expand
Arimidex: Compliance and arthralgias in clinical therapy (COMPACT): An in practice assessment of arthralgias and related costs as well as compliance in the first year of anastrozole therapy
- Study Id
- NIS-ODE-ARI-2008/1
- Disease
- breast cancer
- Drug Name
- Arimidex
- Study Name
- NIS-ODE-ARI-2008/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Sep 17, 2012
